ESG Report 2020

During the Year, the outbreak of the coronavirus pandemic medicines and supplies, providing disease has dealt a serious blow to society. Anti- technological support and donating in cash and in pandemic work is directly related to the health and kind. In the meantime, the Group safeguards its safety of many lives, thus as a part of society and employees ’ health and safety with effective the pharmaceutical industry, The United infection control, and pays close attention to the Laboratories strives to convey its vision of “ Making needs of employees. With joint efforts from all Life More Valuable ” by fully cooperating with the sides, the pandemic was under control, and the national and local governments ’ anti-pandemic Group will continue to focus on infection control to work. With capability and experience, the Group ensure the safety of its employees and the general and its employees engaged in producing anti- public. At the beginning of the outbreak, the Group was stable supply chain of bulk medicines at home and aware of Wuhan s urgent need of support from all abroad. sides. We have set the policy of “ Full Support for The Group s management convened an emergency Wuhan, Fight against Pandemic Together ” , meeting right after the outbreak to discuss targeting to combat the pandemic with joint efforts arrangements for resumption of work and from employees and the management. To meet the pandemic supports. Some production units in demand of medicines in clinical use during the factories were decided not to take the Chinese pandemic, the Group promptly arranged relevant New Year holiday and continued their production. factories and employees to resume work in Under the threat of the coronavirus, the employees advance, and sped up the production of unanimously agreed with the management's pharmaceuticals. The Group also effectively decision and stayed on the manufacturing frontline communicated and coordinated with the logistics to produce medicines of urgent need. The and shipment and ensured the production and employees achieved production targets and supply of upstream intermediate products and bulk supported Wuhan with effective actions. medicines, contributing to the maintenance of ’ ’ Since the very beginning of the outbreak, the pandemic by producing supplies and providing Group was highly concerned and fully cooperated technological assistance. Other than direct with the and local governments anti- support, the Group and its employees also donated pandemic work. As an outstanding pharmaceutical in cash and in kind to support the healthcare company with years of experience and system and the general public, fighting against technological expertise, the Group leveraged its pandemic with society. strengths and helped in fighting against the national ’ FIGHT AGAINST PANDEMIC WITH PROMPT ACTIONS Special Arrangements for Resumption of Work 10 Environmental, Social and Governance Report 2020 The United Laboratories International Holdings Limited